175 related articles for article (PubMed ID: 29070615)
1. Mitochondrial Haplotype Alters Mammary Cancer Tumorigenicity and Metastasis in an Oncogenic Driver-Dependent Manner.
Brinker AE; Vivian CJ; Koestler DC; Tsue TT; Jensen RA; Welch DR
Cancer Res; 2017 Dec; 77(24):6941-6949. PubMed ID: 29070615
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial polymorphisms contribute to aging phenotypes in MNX mouse models.
Vivian CJ; Hagedorn TM; Jensen RA; Brinker AE; Welch DR
Cancer Metastasis Rev; 2018 Dec; 37(4):633-642. PubMed ID: 30547266
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial Haplotype of the Host Stromal Microenvironment Alters Metastasis in a Non-cell Autonomous Manner.
Brinker AE; Vivian CJ; Beadnell TC; Koestler DC; Teoh ST; Lunt SY; Welch DR
Cancer Res; 2020 Mar; 80(5):1118-1129. PubMed ID: 31848195
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial Genomic Backgrounds Affect Nuclear DNA Methylation and Gene Expression.
Vivian CJ; Brinker AE; Graw S; Koestler DC; Legendre C; Gooden GC; Salhia B; Welch DR
Cancer Res; 2017 Nov; 77(22):6202-6214. PubMed ID: 28663334
[TBL] [Abstract][Full Text] [Related]
5. Effects of FVB/NJ and C57Bl/6J strain backgrounds on mammary tumor phenotype in inducible nitric oxide synthase deficient mice.
Davie SA; Maglione JE; Manner CK; Young D; Cardiff RD; MacLeod CL; Ellies LG
Transgenic Res; 2007 Apr; 16(2):193-201. PubMed ID: 17206489
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial DNA lesions and copy number are strain dependent in endurance-trained mice.
Vellers HL; Massett MP; Avila JJ; Kim SK; Marzec JM; Santos JH; Lightfoot JT; Kleeberger SR
Physiol Rep; 2020 Nov; 8(21):e14605. PubMed ID: 33190396
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial Genetics Regulate Breast Cancer Tumorigenicity and Metastatic Potential.
Feeley KP; Bray AW; Westbrook DG; Johnson LW; Kesterson RA; Ballinger SW; Welch DR
Cancer Res; 2015 Oct; 75(20):4429-36. PubMed ID: 26471915
[TBL] [Abstract][Full Text] [Related]
8. Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice.
Boggio K; Di Carlo E; Rovero S; Cavallo F; Quaglino E; Lollini PL; Nanni P; Nicoletti G; Wolf S; Musiani P; Forni G
Cancer Res; 2000 Jan; 60(2):359-64. PubMed ID: 10667588
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk from non-cancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways.
Kaipparettu BA; Ma Y; Park JH; Lee TL; Zhang Y; Yotnda P; Creighton CJ; Chan WY; Wong LJ
PLoS One; 2013; 8(5):e61747. PubMed ID: 23671572
[TBL] [Abstract][Full Text] [Related]
10. Mammary tumorigenesis and metastasis in transgenic mice.
Webster MA; Muller WJ
Semin Cancer Biol; 1994 Feb; 5(1):69-76. PubMed ID: 8186390
[TBL] [Abstract][Full Text] [Related]
11. Prime-boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu+ metastatic breast cancer in mice.
Wang X; Wang JP; Rao XM; Price JE; Zhou HS; Lachman LB
Breast Cancer Res; 2005; 7(5):R580-8. PubMed ID: 16168101
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility loci affecting ERBB2/neu-induced mammary tumorigenesis in mice.
Quan L; Dittmar A; Zhou Y; Hutson A; Stassen AP; Demant P
Genes Chromosomes Cancer; 2012 Jul; 51(7):631-43. PubMed ID: 22419448
[TBL] [Abstract][Full Text] [Related]
13. Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.
Chatterjee G; Rosner A; Han Y; Zelazny ET; Li B; Cardiff RD; Perkins AS
Am J Pathol; 2002 Dec; 161(6):2241-53. PubMed ID: 12466138
[TBL] [Abstract][Full Text] [Related]
14. Detection of different tumor growth kinetics in single transgenic mice with oncogene-induced mammary carcinomas by flat-panel volume computed tomography.
Jannasch K; Dullin C; Heinlein C; Krepulat F; Wegwitz F; Deppert W; Alves F
Int J Cancer; 2009 Jul; 125(1):62-70. PubMed ID: 19384954
[TBL] [Abstract][Full Text] [Related]
15. Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants.
Moreno-Loshuertos R; Acín-Pérez R; Fernández-Silva P; Movilla N; Pérez-Martos A; Rodriguez de Cordoba S; Gallardo ME; Enríquez JA
Nat Genet; 2006 Nov; 38(11):1261-8. PubMed ID: 17013393
[TBL] [Abstract][Full Text] [Related]
16. A specific nuclear DNA background is required for high frequency lymphoma development in transmitochondrial mice with G13997A mtDNA.
Hashizume O; Yamanashi H; Taketo MM; Nakada K; Hayashi J
PLoS One; 2015; 10(3):e0118561. PubMed ID: 25738506
[TBL] [Abstract][Full Text] [Related]
17. Dysfunctional telomeres promote genomic instability and metastasis in the absence of telomerase activity in oncogene induced mammary cancer.
Bojovic B; Crowe DL
Mol Carcinog; 2013 Feb; 52(2):103-17. PubMed ID: 22086874
[TBL] [Abstract][Full Text] [Related]
18. Proteotypic classification of spontaneous and transgenic mammary neoplasms.
Mikaelian I; Blades N; Churchill GA; Fancher K; Knowles BB; Eppig JT; Sundberg JP
Breast Cancer Res; 2004; 6(6):R668-79. PubMed ID: 15535849
[TBL] [Abstract][Full Text] [Related]
19. Decreased physical performance of congenic mice with mismatch between the nuclear and the mitochondrial genome.
Nagao Y; Totsuka Y; Atomi Y; Kaneda H; Lindahl KF; Imai H; Yonekawa H
Genes Genet Syst; 1998 Feb; 73(1):21-7. PubMed ID: 9546205
[TBL] [Abstract][Full Text] [Related]
20. Somatic alterations in mitochondrial DNA produce changes in cell growth and metabolism supporting a tumorigenic phenotype.
Jandova J; Shi M; Norman KG; Stricklin GP; Sligh JE
Biochim Biophys Acta; 2012 Feb; 1822(2):293-300. PubMed ID: 22119597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
